WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke ENOVANT wurde als Wortmarke am 11.09.2018 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1454917 |
| Registernummer | 720508 |
| Länder | 
|
| Basismarke |
Nr. 720508,
13. März 2018
|
| Anmeldedatum | 11. September 2018 |
| Ablaufdatum | 11. September 2028 |
Markeninhaber
Viaduktstrasse 8
4051 Basel
CH
4051 Basel
CH
Markenvertreter
Fross Zelnick Lehrman & Zissu, P.C.
4 Times Square, 17th Floor
US
Waren und Dienstleistungen
09
Calculating machines, data processing equipment, computer
equipment; computer software; computer software for
providing, analyzing and generating reports; computer
software for data processing; electronic apparatus,
electronic devices, software, programs and systems for the
capture, collection, conversion, analysis, communication,
processing, receiving, recording, storage and/or
transmission of data, images, information; computer
software for database integration; computer software for
creating searchable databases of information and data;
software for analytics in the fields of public health,
healthcare, pharmaceutical and biomedical research and
development, clinical trials and post-authorization research
for the marketing of medicines and/or commercial
post-launching of medicines, and the provision of medical
and healthcare services; downloadable computer software
featuring computer databases containing information in the
pharmaceutical and medical field; downloadable computer
search engine software for accessing and providing updated
scientific, medical and clinical information, and for
accessing and providing news information of general
interest; computer software for accessing, controlling and
managing data and information related to healthcare services
and patient medical information
35
Business consulting services; business research services;
business information services; market research; provision
of market research information; data processing services;
analysis of business data; business advisory services,
consultancy and information; market intelligence services
in the fields of pharmaceuticals, biomedicine, clinical
trials, post-authorization research for the marketing of
medicines and/or commercial post-launching of medicines,
epidemiological research, pharmaco-epidemiological research,
public health and healthcare; competitive intelligence
services in the fields of pharmaceuticals, biomedicine,
clinical trials, post-authorization research for the
marketing of medicines and/or commercial post-launching of
medicines, epidemiological research,
pharmaco-epidemiological research, public health and
healthcare; professional business analysis and consultancy
and statistical analysis in the fields of public health,
healthcare, biomedicine, pharmaceuticals, clinical trials,
post-authorization research for the marketing of medicines
and/or commercial post-launching of medicines,
epidemiological research, pharmaco-epidemiological research
and research evaluating epidemiological outcomes; providing
information regarding market intelligence services and
competitive intelligence services in the fields of
pharmaceuticals, biomedicine, clinical trials,
post-authorization research for the marketing of medicines
and/or commercial post-launching of medicines,
epidemiological research, pharmaco-epidemiological research,
public health and healthcare from an on-line database;
arranging of commercial and business contacts within the
scientific research and medical communities to achieve
advances in the field of healthcare; business networking
services within the scientific research and medical
communities to achieve advances in the field of healthcare;
compilation of data, analysis of business data and
professional business analysis in the field of
pharmaceutical and biomedical research and development,
clinical trials, post-authorization research for the
marketing of medicines and/or commercial post-launching of
medicines, epidemiological research,
pharmaco-epidemiological research, public health and
healthcare; compilation of data, analysis of business data
and professional business analysis for medical, public
health and healthcare purposes; providing reimbursement
comparative evaluation information and other market
intelligence to healthcare organizations; collecting
insurance claims data and business analysis of insurance
claims data from health and health care organizations for
commercial purposes; business services provided to the
healthcare industry, namely, the collection, reporting, and
professional business analysis of healthcare data for
business purposes; compiling data for research and analysis
purposes in the fields of public health and healthcare,
pharmaceuticals, biomedicine, clinical trials and
post-authorization research for the marketing of medicines
and/or commercial post-launching of medicines
36
Financial analysis; financial consulting; financial
valuations and forecasting; financial analysis, namely,
financial analysis of statistics and data as well as
compilation of statistics; financial analysis of
investments in pharmaceutical and biomedical research and
development and clinical trials and post-authorization
research for the marketing of medicines and/or commercial
post-launching of medicines; providing financial services
with respect to securities and other financial instruments
and products, namely, trading of and investments in
securities and financial instruments and products for
others; financial evaluation, tracking, analysis,
forecasting, consultancy, advisory and research services
relating to securities and other financial instruments;
research related to financial instruments
42
Scientific and technological services and research and
design relating thereto; industrial analysis and research
services; design and development of computer hardware and
software; data processing analysis services; analysis of
scientific data; pharmaceutical and biomedical research
services; clinical trials; pharmaceutical and biomedical
research services, namely post-authorization research for
the marketing of medicines and/or commercial post-launching
of medicines; epidemiological research services;
pharmaco-epidemiological research services; providing
temporary use of non-downloadable software applications
accessible via a web site regarding analytics of data for
use in the fields of public health and healthcare,
pharmaceuticals, biomedicine, clinical trials and
post-authorization research for the marketing of medicines
and/or commercial post-launching of medicines,
epidemiological research and pharmaco-epidemiological
research; providing on-line information in the fields of
pharmaceutical research, biomedical research,
epidemiological research, pharmaco-epidemiological research
and data from clinical trials and post-authorization
research for the marketing of medicines and/or commercial
post-launching of medicines from a computer database or the
Internet; providing scientific research information in the
fields of public health and healthcare, biomedicine,
pharmaceuticals, clinical trials and post-authorization
research for the marketing of medicines and/or commercial
post-launching of medicines; providing temporary use of
non-downloadable software applications accessible via a web
site for data analytics and financial analytics for use in
the fields of pharmaceutical and biomedical research and
development, clinical trials, and the provision of medical
and healthcare services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 24. September 2020 | 2020/40 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 21. Mai 2020 | 2020/22 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 07. Mai 2020 | 2020/19 Gaz | JP | Ablehnung |
| 09. April 2020 | 2020/22 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 01. Dezember 2019 | 2019/49 Gaz | KR | Ablehnung |
| 19. August 2019 | 2019/34 Gaz | EM | Ablehnung |
| 29. Mai 2019 | 2019/22 Gaz | GB | Ablehnung |
| 22. Mai 2019 | 2019/22 Gaz | SG | Ablehnung |
| 11. September 2018 | 2019/9 Gaz | CH | Eintragung |
ID: 141454917